2322 studies found for:    Open Studies | "Drug Therapy"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Drug Therapy"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
Condition: Chemotherapy-induced Febrile Neutropenia
Intervention:
2 Recruiting Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma;   Effects of Chemotherapy
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
3 Recruiting Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Olanzapine
4 Unknown  Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor
Conditions: Gastric Cancer;   Colorectal Cancer;   Chemotherapy
Interventions: Drug: Nutriall;   Drug: LDEPA;   Drug: Placebo;   Drug: HDEPA;   Drug: Chemotherapy
5 Unknown  Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm
Conditions: Breast Cancer;   Chemotherapy
Interventions: Drug: Taxotere , Epirubicin;   Drug: E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP
6 Recruiting Characterization and Treatment of Chemotherapy Neuropathy
Condition: Chemotherapy-induced Neuropathy
Interventions: Procedure: Photon stimulation;   Procedure: Placebo treatment
7 Unknown  A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy
Conditions: Breast Cancer;   Chemotherapy;   Neutropenia
Intervention: Other: EW02
8 Not yet recruiting Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy Management
Condition: Chemotherapy-induced Peripheral Neuropathy
Intervention: Drug: Dextromethorphan
9 Unknown  Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Conditions: Chemotherapy-Induced Neutropenia;   Breast Cancer
Intervention: Biological: Maxy-G34
10 Recruiting Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy
Conditions: Gastrointestinal Neoplasms;   Colorectal Cancer;   Effects of Chemotherapy;   Tumor Immunity;   Malnutrition
Interventions: Drug: Probiotic;   Drug: placebo(for probiotic)
11 Recruiting Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention:
12 Unknown  Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy
Conditions: Breast Cancer;   Bevacizumab;   Neoadjuvant Chemotherapy;   Molecular Targeted Therapy
Intervention: Drug: bevacizumab
13 Recruiting Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.
Conditions: Neoplasm, Ureter;   Intravesical Chemotherapy;   Radical Nephroureterectomy;   Neoplasm, Bladder
Interventions: Drug: Immediate instillation of intravesical chemotherapy-Epirubicin-;   Drug: Maintainance therapy of intravesical chemotherapy-Epirubicin-
14 Not yet recruiting The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Other: Verum acupuncture and medicine;   Other: Sham acupuncture and medicine
15 Recruiting Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Olanzapine;   Drug: Aprepitant;   Drug: Palonosetron;   Drug: Dexamethasone
16 Not yet recruiting Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Conditions: Breast Cancer;   Chemotherapy Induced Amenorrhea;   Ovarian Function Suppression
Interventions: Drug: Goserelin;   Drug: Toremifene
17 Unknown  Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia
Condition: Antineoplastic Chemotherapy Induced Anemia
Intervention: Biological: Epoetin alfa
18 Not yet recruiting Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy
Conditions: Chemotherapy-Induced Nausea and Vomiting;   Lung Cancer
Interventions: Drug: Aprepitant;   Drug: Palonosetron;   Drug: Dexamethasone
19 Recruiting A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
Conditions: Taxane-induced Peripheral Neuropathy;   Chemotherapy-induced Peripheral Neuropathy (CIPN);   Early-Stage Breast Carcinoma;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Interventions: Procedure: Immediate Acupuncture Group;   Procedure: Delayed Acupuncture Group
20 Recruiting Nutrition Intervention During Chemotherapy
Condition: Cancer Patients Receiving Chemotherapy or Chemoradiotherapy
Intervention: Dietary Supplement: Daily intake for 10 weeks (+/- 2 weeks)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years